GGrantIndex
← Leaderboards

H-H. Sherry Chow

University Of Arizona

Google Scholar ↗PubMed ↗ORCID ↗
$11,619,049
Attributed
$15,488,447
Total exposure
13
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY2009–25
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,488,447 · 13

By mechanism

UG1$7,738,796 · 1
R01$2,810,281 · 1
P30$2,278,168 · 6
P01$1,549,162 · 2
R21$532,510 · 1
S10$504,397 · 1

Top collaborators

Most similar at University Of Arizona

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

Research focus

Malignant NeoplasmsBiological MarkersArizonaCancer RiskProgramsResourcesPreventiveUniversitiesBiologicalCancer CenterResearch PersonnelCancer Center Support GrantClinical ResearchSpecimenResource SharingBiochemicalCollaborationsMemberGrantPharmaceutical PreparationsMeasurementEnvironmental Risk FactorDesignLifestyle Factors

Grant awards (55)

Analytical Chemistry Shared Resource (ACSR)$142,552
P30 · FY2025 · CA · contact PI
Analytical Chemistry Shared Resource (ACSR)$132,286
P30 · FY2024 · CA · contact PI
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)$1,507,039
UG1 · FY2023 · CA · contact PI
Ultra-performance liquid chromatography - triple quadrupole mass spectrometry system$504,397
S10 · FY2023 · OD · contact PI
Core C: Molecular Targets$303,549
P01 · FY2023 · CA · contact PI
Analytical Chemistry Shared Resource (ACSR)$132,286
P30 · FY2023 · CA · contact PI
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)$1,119,544
UG1 · FY2022 · CA · contact PI
Core C: Molecular Targets$295,778
P01 · FY2022 · CA · contact PI
Analytical Chemistry Shared Resource (ACSR)$128,380
P30 · FY2022 · CA · contact PI
Cancer Prevention and Control Program (CPCP)$68,668
P30 · FY2022 · CA · contact PI
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)$1,918,750
UG1 · FY2021 · CA · contact PI
Core C: Molecular Targets$296,181
P01 · FY2021 · CA · contact PI
Analytical Chemistry$187,962
P30 · FY2021 · CA · contact PI
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)$157,669
UG1 · FY2021 · CA · contact PI
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)$1,918,750
UG1 · FY2020 · CA · contact PI
Core C: Molecular Targets$322,534
P01 · FY2020 · CA · contact PI
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)$157,669
UG1 · FY2020 · CA · contact PI
Analytical Chemistry$107,799
P30 · FY2020 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$28,005
P30 · FY2020 · CA · contact PI
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)$959,375
UG1 · FY2019 · CA · contact PI
Core C: Molecular Targets$331,120
P01 · FY2019 · CA · contact PI
Analytical Chemistry$108,237
P30 · FY2019 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$28,444
P30 · FY2019 · CA · contact PI
Analytical Chemistry$22,223
P30 · FY2019 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$22,222
P30 · FY2019 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$11,939
P30 · FY2019 · CA · contact PI
Analytical Chemistry$11,939
P30 · FY2019 · CA · contact PI
Metformin for Reduction of Obesity Associated Breast Cancer Risk$330,861
R01 · FY2018 · CA · contact PI
Analytical Chemistry$109,819
P30 · FY2018 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$30,027
P30 · FY2018 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$16,667
P30 · FY2018 · CA · contact PI
Analytical Chemistry$16,667
P30 · FY2018 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$13,889
P30 · FY2018 · CA · contact PI
Analytical Chemistry$13,889
P30 · FY2018 · CA · contact PI
Analytical Chemistry$11,112
P30 · FY2018 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$11,110
P30 · FY2018 · CA · contact PI
Analytical Chemistry$6,223
P30 · FY2018 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$6,221
P30 · FY2018 · CA · contact PI
Metformin for Reduction of Obesity Associated Breast Cancer Risk$511,097
R01 · FY2017 · CA · contact PI
Analytical Chemistry$84,699
P30 · FY2017 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$954
P30 · FY2017 · CA · contact PI
Metformin for Reduction of Obesity Associated Breast Cancer Risk$628,563
R01 · FY2016 · CA · contact PI
Analytical Chemistry$106,288
P30 · FY2016 · CA · contact PI
Program 4: Cancer Prevention and Control Program (CPC)$26,495
P30 · FY2016 · CA · contact PI
Metformin for Reduction of Obesity Associated Breast Cancer Risk$248,563
R01 · FY2015 · CA · contact PI
Metformin for Reduction of Obesity Associated Breast Cancer Risk$577,686
R01 · FY2014 · CA · contact PI
Metformin for Reduction of Obesity Associated Breast Cancer Risk$513,511
R01 · FY2013 · CA · contact PI
Analytical Core$124,399
P30 · FY2013 · CA · contact PI
Analytical Core$134,132
P30 · FY2012 · CA · contact PI
Analytical Core$140,931
P30 · FY2011 · CA · contact PI
Clinical Study of Disposition and Biological Activity of d-Limonene$299,970
R21 · FY2010 · CA · contact PI
Analytical Core$149,284
P30 · FY2010 · CA · contact PI
Clinical Study of Disposition and Biological Activity of d-Limonene$232,540
R21 · FY2009 · CA · contact PI
Analytical Core$142,420
P30 · FY2009 · CA · contact PI
DIRECT NOSE/BRAIN DRUG/PEPTIDE TRANSPORT$75,133
R03 · FY2000 · DA